» Articles » PMID: 39293757

Prenatal Exposure to Phthalates and Childhood Wheeze and Asthma in the PROGRESS Cohort

Abstract

Introduction: Prenatal phthalate exposure may influence lung development and lead to wheezing and asthma in childhood, and these associations may vary by sex. Despite ubiquity of exposure, there is limited epidemiologic data on these associations in Latin America.

Methods: We assessed 593 mother-child dyads enrolled in the Programming Research in Obesity, Growth, Environment, and Social Stressors birth cohort in Mexico City. We quantified 15 phthalate metabolites in 2nd and 3rd trimester maternal urine. Report of ever wheeze, wheeze in the past 12 months (current wheeze) and ever asthma were obtained using a validated survey when children were 4 and 6 years of age. We examined individual associations with modified Poisson models. Mixture effects were assessed using Bayesian Weighted Quantile Sum (BWQS) regression. All models were adjusted for child's sex, maternal age and education at enrollment, and parity.

Results: In Poisson models, a doubling of mono (carboxy-isononyl) phthalate (MCNP) during the 2nd trimester was associated with higher risk of wheeze (RR: 1.14, 95 % CI: 1.01, 1.29), and asthma (RR: 1.44, 95 % CI: 1.05, 1.97) at 4 years of age. Higher concentrations of the sum of di-isononyl phthalate metabolites (∑DiNP) during the 2nd trimester were also associated with asthma at 4 years of age (RR: 1.30, 95 % CI: 1.04, 1.61). Mixture associations of phthalate metabolite concentrations during the 2nd trimester and asthma at 4 years of age were stronger in males (BWQS, OR: 1.94, 95 % CI: 0.90, 4.60; 90 % CrI: 1.04, 3.73) compared to females (BWQS, OR: 1.23, 95 % CI: 0.56, 2.88; 90 % CrI: 0.61, 2.55). Additionally, we observed stronger inverse associations between prenatal phthalate mixtures during the 3rd trimester and current wheeze at 4 and 6 years of age in females (BWQS, OR: 0.54, 90 % CrI: 0.35, 0.82; OR: 0.45, 90 % CrI: 0.22, 0.84) compared to males (BWQS, OR: 0.95, 90 % Cri: 0.68, 1.35; OR: 0.97, 90 % CrI: 0.59, 1.54).

Conclusions: Prenatal phthalate metabolite concentrations were associated with respiratory outcomes in childhood, with some evidence of sex specific effects. Future work investigating phthalate exposure and wheeze trajectories/lung function will be important for understanding how these may predict later disease.

References
1.
Wigglesworth J . Lung development in the second trimester. Br Med Bull. 1988; 44(4):894-908. DOI: 10.1093/oxfordjournals.bmb.a072299. View

2.
Adibi J, Whyatt R, Williams P, Calafat A, Camann D, Herrick R . Characterization of phthalate exposure among pregnant women assessed by repeat air and urine samples. Environ Health Perspect. 2008; 116(4):467-73. PMC: 2291011. DOI: 10.1289/ehp.10749. View

3.
Cantonwine D, Cordero J, Rivera-GonzAlez L, Del Toro L, Ferguson K, Mukherjee B . Urinary phthalate metabolite concentrations among pregnant women in Northern Puerto Rico: distribution, temporal variability, and predictors. Environ Int. 2013; 62:1-11. PMC: 3874859. DOI: 10.1016/j.envint.2013.09.014. View

4.
Zhang Q, Chen X, Huang X, Wang M, Wu J . The association between prenatal exposure to phthalates and cognition and neurobehavior of children-evidence from birth cohorts. Neurotoxicology. 2019; 73:199-212. DOI: 10.1016/j.neuro.2019.04.007. View

5.
Wu H, Just A, Colicino E, Calafat A, Oken E, Braun J . The associations of phthalate biomarkers during pregnancy with later glycemia and lipid profiles. Environ Int. 2021; 155:106612. PMC: 8292182. DOI: 10.1016/j.envint.2021.106612. View